Nutrastar International Inc. Asset Turnover Ratio (NUIN), as of third quarter 2015, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Nutrastar International Inc.  (NUIN)
 

Nutrastar International Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Nutrastar International's asset turnover ratio, the ratio that measures the ability of Nutrastar International's assets to generate revenue, sequentially decreased to 0.29 in the third quarter (Sep 30 2015), which does not come as a surprise, as the Nutrastar International continue to experience difficult business climate.

Within sector 14 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Third Quarter 2015 compared to the preceding quarter from 29 to 2867.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NUIN Asset Turnover Ratio (Sep 30 2015)
III. Quarter		 (Jun 30 2015)
II. Quarter		 (Mar 31 2015)
I. Quarter		 (Dec 31 2014)
IV. Quarter		 (Sep 30 2014)
III. Quarter
Y / Y Asset Change 13.44 % 18.79 % 19.34 % 18.61 % 20.56 %
Y / Y Revenue Change -1.31 % 1.84 % 2.56 % -6.36 % 2.09 %
Asset Turnover Ratio (TTM) 0.29 0.3 0.31 0.33 0.35
NUIN's Total Ranking # 2867 # 29 # 2867 # 29 # 29
Seq. Asset Change -0.21 % 6.48 % 1.08 % 5.62 % 4.5 %
Seq. Revenue Change -16.8 % 88.05 % -42.71 % 10.1 % -14.15 %



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 15
Healthcare Sector # 283
Overall Market # 2867

Asset Turnover Ratio Statistics
High Average Low
0.43 0.36 0.29
(Dec 31 2012)   (Sep 30 2015)




NUIN Company Profile • Back to NUIN Efficiency Comparisons • Compare NUIN Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2015, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2015 Assets at quarter ending Sep 30 2015
Atricure Inc   0.77 $ 123.307  Millions$ 159.190  Millions
Gilead Sciences Inc   0.77 $ 31,447.000  Millions$ 40,697.250  Millions
Proteo Inc  0.77 $ 0.761  Millions$ 0.989  Millions
Neogen Corporation  0.76 $ 290.335  Millions$ 381.326  Millions
Retractable Technologies Inc  0.75 $ 33.094  Millions$ 43.880  Millions
Resmed Inc   0.75 $ 1,710.160  Millions$ 2,269.483  Millions
Tearlab Corp  0.75 $ 23.662  Millions$ 31.441  Millions
Quest Diagnostics Inc  0.75 $ 7,527.000  Millions$ 10,071.000  Millions
Positron Corporation  0.74 $ 1.237  Millions$ 1.679  Millions
Rti Surgical Holdings Inc   0.73 $ 277.045  Millions$ 377.746  Millions
United Therapeutics Corporation  0.73 $ 1,407.249  Millions$ 1,918.770  Millions
Zoetis Inc   0.73 $ 4,811.000  Millions$ 6,580.250  Millions
Enanta Pharmaceuticals Inc  0.73 $ 160.880  Millions$ 221.272  Millions
Cyteir Therapeutics Inc   0.72 $ 2,005.300  Millions$ 2,768.600  Millions
Intelgenx Technologies Corp   0.72 $ 4.418  Millions$ 6.162  Millions
Incyte Corporation  0.71 $ 633.843  Millions$ 888.741  Millions
Merit Medical Systems Inc  0.71 $ 536.525  Millions$ 752.588  Millions
Globus Medical Inc   0.70 $ 530.967  Millions$ 753.250  Millions
Charles River Laboratories International inc   0.70 $ 1,339.000  Millions$ 1,912.795  Millions
Pra Health Sciences Inc   0.70 $ 1,554.900  Millions$ 2,228.199  Millions
Pacific Biosciences Of California Inc   0.69 $ 73.405  Millions$ 106.873  Millions
Agilent Technologies inc   0.68 $ 5,064.000  Millions$ 7,415.250  Millions
Bard C R Inc  0.68 $ 3,412.400  Millions$ 5,022.300  Millions
Integer Holdings Corporation  0.68 $ 652.573  Millions$ 963.121  Millions
Icad Inc  0.67 $ 47.110  Millions$ 69.837  Millions
Edwards Lifesciences Corporation  0.67 $ 2,440.600  Millions$ 3,624.400  Millions
Veracyte Inc   0.67 $ 47.660  Millions$ 70.814  Millions
Pediatrix Medical Group Inc   0.67 $ 2,688.781  Millions$ 4,019.186  Millions
Navidea Biopharmaceuticals Inc   0.67 $ 10.416  Millions$ 15.630  Millions
Surmodics Inc   0.66 $ 61.898  Millions$ 93.129  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.